GSK Shares Slide on Weaker Vaccine Sales in China
The FTSE 100 drugmaker reports that falling demand in China has reduced sales of its shingles vaccine.
Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made
First reported by News Feed, 1h 11m ahead of the next publisher · who breaks stories first
The story so far
3 publishers have covered this in 3 articles since 28 Oct 2026. News Feed published first, on 28 October at 10:39 UTC; Quartz followed 1h 11m later. The most recent article, from The Guardian Business, appeared on 28 October at 12:44 UTC.
Outlets reporting it: News Feed (major outlet), The Guardian Business (major outlet), Quartz.
No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.
How it unfolded
Every source in the order it published.
Sources
Every article we clustered into this story. Headlines link to the publisher.
In this story
- GSK